Related Experiment Video
Updated: Aug 9, 2025

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via
Gongsheng Yuan1, Shuting Yang1, Shuying Yang2,3,4
1Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, USA.
Abstract:
Tumor-associated macrophages (TAMs) play crucial roles in tumor progression and immune responses. However, mechanisms of driving TAMs to antitumor function remain unknown. Here, transcriptome profiling analysis of human oral cancer tissues indicated that regulator of G protein signaling 12 (RGS12) regulates pathologic processes and immune-related pathways. Mice with RGS12 knockout in macrophages displayed decreased M1 TAMs in oral cancer tissues, and extensive proliferation and invasion of oral cancer cells. RGS12 increased the M1 macrophages with features of increased ciliated cell number and cilia length. Mechanistically, RGS12 associates with and activates MYC binding protein 2 (MYCBP2) to degrade the cilia protein kinesin family member 2A (KIF2A) in TAMs. Our results demonstrate that RGS12 is an essential oral cancer biomarker and regulator for immunosuppressive TAMs activation.
Insights
Regulator of G protein signaling 12 (RGS12) drives antitumor function in tumor-associated macrophages (TAMs) by promoting M1 polarization. This discovery offers a new target for oral cancer therapy by reprogramming immunosuppressive TAMs.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor-associated macrophages (TAMs) are critical in tumor progression and immune evasion.
- Mechanisms to redirect TAMs towards antitumor functions are largely unknown.
- Oral cancer progression involves complex immune interactions.
Purpose of the Study:
- To investigate the role of Regulator of G protein signaling 12 (RGS12) in oral cancer.
- To elucidate the mechanisms by which RGS12 influences TAM polarization and function.
- To identify RGS12 as a potential biomarker and therapeutic target in oral cancer.
Main Methods:
- Transcriptome profiling of human oral cancer tissues.
- Analysis of RGS12 knockout mice models in oral cancer.
- Investigation of RGS12 interactions with MYCBP2 and KIF2A in TAMs.
Main Results:
- RGS12 was identified as a regulator of immune-related pathways in oral cancer.
- RGS12 knockout in macrophages led to decreased M1 TAMs and increased oral cancer cell proliferation/invasion.
- RGS12 promotes M1 macrophage polarization by activating MYCBP2 to degrade KIF2A, enhancing cilia.
- RGS12 acts as a biomarker and regulator of immunosuppressive TAM activation.
Conclusions:
- RGS12 is a key regulator of TAM polarization towards an antitumor M1 phenotype.
- Targeting RGS12 could reprogram immunosuppressive TAMs for oral cancer treatment.
- RGS12 represents a promising biomarker for oral cancer prognosis and therapeutic strategy.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

